Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

Por Hembruff, Stacey L, Laberge, Monique L, Villeneuve, David J, Guo, Baoqing, Veitch, Zachary, Cecchetto, Melanie, Parissenti, Amadeo M
Publicado em 2008

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program

Por Veitch, Zachary W., Fasih, Samir, Griffin, Anthony M., Al‐Ezzi, Esmail M., Gupta, Abha A., Ferguson, Peter C., Wunder, Jay S., Abdul Razak, Albiruni R.
Publicado no Cancer Med (2020)

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)

Por Veitch, Zachary, Zer, Alona, Loong, Herbert, Salah, Samer, Masood, Maryam, Gupta, Abha, Bradbury, Penelope A., Hogg, David, Wong, Andrew, Kandel, Rita, Charames, George S., Abdul Razak, Albiruni R.
Publicado no Sci Rep (2019)

Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Ou...

Por Albaba, Hamzeh, Barnes, Tristan A., Veitch, Zachary, Brown, M. Catherine, Shakik, Sharara, Su, Susie, Naik, Hiten, Wang, Tian, Liang, Mindy, Perez‐Cosio, Andrea, Eng, Lawson, Mittmann, Nicole, Xu, Wei, Howell, Doris, Liu, Geoffrey
Publicado no Oncologist (2019)

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

Por Veitch, Zachary W., Cescon, David W., Denny, Trisha, Yonemoto, Lisa-Maria, Fletcher, Graham, Brokx, Richard, Sampson, Peter, Li, Sze-Wan, Pugh, Trevor J., Bruce, Jeffrey, Bray, Mark R., Slamon, Dennis J., Mak, Tak W., Wainberg, Zev A., Bedard, Philippe L.
Publicado no Br J Cancer (2019)